Spondyloarthritis & psoriatic arthritis
Opioid Use and Healthcare Utilization in Adults With Psoriatic Arthritis and Ankylosing Spondylitis
Authors' conclusion
Compared to patients not using opioids, patients with PsA and AS who used opioids had higher healthcare utilization and higher health-related costs.
Study context
- Population
- Adults with PsA or ankylosing spondylitis (AS) in the FORWARD registry with ≥ 1 completed disease activity or disability questionnaire, 2010–2019828 PsA
- Exposure
- Opioid users vs nonusers
- Outcome
- Annualized healthcare utilization and prescription costs
Methodological detailsFORWARD registry, negative binomial regression, generalized linear models with γ-distribution and log link, adjusted for age, sex and hospitalization, PsA and AS studied separately
- FORWARD registry
- Negative binomial regression
- Generalized linear models with γ-distribution and log link
- Adjusted for age, sex and hospitalization
- PsA and AS studied separately
Main finding
As reported in the abstract
Medical visit spending annually (PsA) · annual
Observational data: associations, not effects.
Further findings
Medical visit spending annually (AS) · annual
Prevalence of opioid use
- PsA (n=828)
- 21.4%
- AS (n=334)
- 27.2%
Original publication
Opioid Use and Healthcare Utilization in Adults With Psoriatic Arthritis and Ankylosing Spondylitis. J Rheumatol. Published 15 August 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →